EphrinB/EphB signaling contributes to spinal nociceptive processing via calpain‑1 and caspase‑3

Yang,Mei; Chen,Wei; Zhang,Yu; Yang,Rui; Wang,Yiru; Yuan,Hongbin

doi:10.3892/mmr.2018.8996

EphrinB/EphB signaling contributes to spinal nociceptive processing via calpain‑1 and caspase‑3

Authors:
- Mei Yang
- Wei Chen
- Yu Zhang
- Rui Yang
- Yiru Wang
- Hongbin Yuan
View Affiliations

Affiliations: Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China
Published online on: May 9, 2018 https://doi.org/10.3892/mmr.2018.8996
Pages: 268-278
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have indicated that an important subfamily of receptor tyrosine kinases, ephrins and their receptors, are important in pain signaling, particularly in spinal nociceptive processing. In the present study, the role of the ephrin/Eph signaling pathway was confirmed, and it was shown that this signaling was also involved in spinal nociceptive processing through the actions of calpain‑1 and caspase‑3. First, the ephrinB ligands, ephrinB1‑Fc or ephrinB2‑Fc, were introduced into experimental mice via intrathecal injection, and it was found that this injection induced marked time‑ and dose‑dependent mechanical allodynia and thermal hyperalgesia, accompanied by increased levels of calpain‑1 and caspase‑3 in the spinal cord. MDL28170, an inhibitor of calpain‑1, reversed the behavioral effects and ameliorated the increases in calpain‑1 and caspase‑3. Second, it was found that the administration of EphB1 between L5 and L6 in mice inhibited the mechanical allodynia and thermal hyperalgesia induced by chronic constrictive injury. In addition, to demonstrate the cell phenotypes responsible for the increased levels of calpain‑1 and caspase‑3 in the spinal cord following injection with ephrinB2‑Fc, double immunofluorescent labeling was performed, which indicated that calpain‑1 and caspase‑3 were localized in neurons, but not in astrocytes or microglial cells. In conclusion, the present study suggested that ephrinB/EphB signaling contributes to spinal nociceptive processing via the actions of calpain‑1 and caspase‑3.

View Figures

View References

1	Doth AH, Hansson PT, Jensen MP and Taylor RS: The burden of neuropathic pain: A systematic review and meta-analysis of health utilities. Pain. 149:338–344. 2010. View Article : Google Scholar : PubMed/NCBI
2	Zhao J, Yuan G, Cendan CM, Nassar MA, Lagerström MC, Kullander K, Gavazzi I and Wood JN: Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain. Mol Pain. 6:772010. View Article : Google Scholar : PubMed/NCBI
3	Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, Park SW, et al: Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science. 330:1400–1404. 2010. View Article : Google Scholar : PubMed/NCBI
4	Chen ZY, Shen FY, Jiang L, Zhao X, Shen XL, Zhong W, Liu S, Wang ZR and Wang YW: Attenuation of neuropathic pain by inhibiting electrical synapses in the anterior cingulate cortex. Anesthesiology. 124:169–183. 2016. View Article : Google Scholar : PubMed/NCBI
5	Chen ZL, Yu WM and Strickland S: Peripheral regeneration. Ann Rev Neurosci. 30:209–233. 2007. View Article : Google Scholar : PubMed/NCBI
6	Xiang XY, Zhang HM, Hu NW, Zhou LJ, Zhang T and Liu XG: A quantitative study of the synaptic alterations in spinal dorsal horn during the induction and maintenance of long-term potentiation. Sheng Li Xue Bao. 56:397–402. 2004.(In Chinese). PubMed/NCBI
7	Kuner R: Central mechanisms of pathological pain. Nat Med. 16:1258–1266. 2010. View Article : Google Scholar : PubMed/NCBI
8	Guan XH, Lu XF, Zhang HX, Wu JR, Yuan Y, Bao Q, Ling DY and Cao JL: Phosphatidylinositol 3-kinase mediates pain behaviors induced by activation of peripheral ephrinBs/EphBs signaling in mice. Pharmacol Biochem Behav. 95:315–324. 2010. View Article : Google Scholar : PubMed/NCBI
9	Klein R: Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat Neurosci. 12:15–20. 2009. View Article : Google Scholar : PubMed/NCBI
10	Zhuang Z, Huang J and Cepero ML: Eph signaling reglates gliotransmitter release. Commum Integr Biol. 4:223–226. 2011. View Article : Google Scholar
11	Bali KK, Venkataramani V, Satagopam VP, Gupta P, Schneider R and Kuner R: Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors. Mol Pain. 9:482013. View Article : Google Scholar : PubMed/NCBI
12	Yang XH, Jiang JT, Yang XY, Han JC and Zheng QS: Licochalcone A induces T24 bladder cancer cell apoptosis by increasing intracellular calcium levels. Mol Med Rep. 14:911–919. 2016. View Article : Google Scholar : PubMed/NCBI
13	Pereira MB, Santos AM, Gonçalves DC, Cardoso AC, Consonni SR, Gozzo FC, Oliveira PS, Pereira AH, Figueiredo AR, Tiroli-Cepeda AO, et al: αB-crystallin interacts with and prevents stress-activated proteolysis of focal adhesion kinase by calpain in cardiomyocytes. Nat Comm. 5:51592014. View Article : Google Scholar
14	Fang J, Liu X, Bolanos L, Barker B, Rigolino C, Cortelezzi A, Oliva EN, Cuzzola M, Grimes HL, Fontanillo C, et al: A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes. Nat Med. 22:727–734. 2016. View Article : Google Scholar : PubMed/NCBI
15	Pörn-Ares MI, Samali A and Orrenius S: Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 5:1028–1033. 1998. View Article : Google Scholar : PubMed/NCBI
16	Li M, Wang X, Yu Y, Yu Y, Xie Y, Zou Y, Ge J, Peng T and Chen R: Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: An in vitro study in H9c2 cells. Virus Res. 179:177–186. 2014. View Article : Google Scholar : PubMed/NCBI
17	Chan SL and Mattson MP: Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res. 58:167–190. 1999. View Article : Google Scholar : PubMed/NCBI
18	Hylden JL and Wilcox GL: Intrathecal morphine in mice: A new technique. Eur J Pharmacol. 67:313–316. 1980. View Article : Google Scholar : PubMed/NCBI
19	Bennett GJ and Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
20	Chaplan SR, Bach FW, Pogrel JW, Chung JM and Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
21	Hargreaves K, Dubner R, Brown F, Flores C and Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988. View Article : Google Scholar : PubMed/NCBI
22	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
23	Zhou XL, Wang Y, Zhang CJ, Yu LN, Cao JL and Yan M: COX-2 is required for the modulation of spinal nociceptive information related to ephrinB/EphB signalling. Eur J Pain. 19:1277–1287. 2015. View Article : Google Scholar : PubMed/NCBI
24	Xia WS, Peng YN, Tang LH, Jiang LS, Yu LN, Zhou XL, Zhang FJ and Yan M: Spinal ephrinB/EphB signalling contributed to remifentanil-induced hyperalgesia via NMDA receptor. Eur J Pain. 18:1231–1239. 2014. View Article : Google Scholar : PubMed/NCBI
25	Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC and Pawson T: The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron. 32:1041–1056. 2001. View Article : Google Scholar : PubMed/NCBI
26	Grunwald IC, Korte M, Wolfer D, Wilkinson GA, Unsicker K, Lipp HP, Bonhoeffer T and Klein R: Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron. 32:1027–1040. 2001. View Article : Google Scholar : PubMed/NCBI
27	Liu S, Liu WT, Liu YP, Dong HL, Henkemeyer M, Xiong LZ and Song XJ: Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents. Cancer Res. 71:4392–4402. 2011. View Article : Google Scholar : PubMed/NCBI
28	Hoogenraad CC, Milstein AD, Ethell IM, Henkemeyer M and Sheng M: GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. Nature Neurosci. 8:906–915. 2005. View Article : Google Scholar : PubMed/NCBI
29	Bundesen LQ, Scheel TA, Bregman BS and Kromer LF: Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci. 23:7789–800. 2003. View Article : Google Scholar : PubMed/NCBI
30	Nwankwo JO, Lei JX, Xu J, Rivera A, Gupta K and Chishti AH: Genetic inactivation of calpain-1 attenuates pain sensitivity in a humanized mouse model of sickle cell disease. Haematologica. 101:e397–e400. 2016. View Article : Google Scholar : PubMed/NCBI
31	Dosemeci A and Reese TS: Effect of calpain on the composition and structure of postsynaptic densities. Synapse. 20:91–97. 1995. View Article : Google Scholar : PubMed/NCBI
32	Wang KK: Calpain and caspase: Can you tell the difference? Trends Neurosci. 23:20–26. 2000. View Article : Google Scholar : PubMed/NCBI
33	Amini M, Ma CL, Farazifard R, Zhu G, Zhang Y, Vanderluit J, Zoltewicz JS, Hage F, Savitt JM, Lagace DC, et al: Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury. J Neurosci. 33:5773–5784. 2013. View Article : Google Scholar : PubMed/NCBI
34	Mouatt-Prigent A, Karisson JO, Agid Y and Hirsch EC: Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: A role in nerve cell death? Neuroscience. 73:979–987. 1996. View Article : Google Scholar : PubMed/NCBI
35	Urthaler F, Wolkowicz PE, Digerness SB, Harris KD and Walker AA: MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc Res. 35:60–67. 1997. View Article : Google Scholar : PubMed/NCBI
36	Li P, Wendy H, He QP, Miyashita H, Siddiqui M and Shuaib A: Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci Lett. 247:17–20. 1998. View Article : Google Scholar : PubMed/NCBI
37	Peng J, Gu N, Zhou L, Eyo B U, Murugan M, Gan WB and Wu LJ: Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun. 7:120292015. View Article : Google Scholar
38	Xu JY, Jiang Y, Liu W and Huang YG: Calpain inhibitor reduces cancer-induced bone pain possibly through inhibition of osteoclastogenesis in rat cancer-induced bone pain model. Chin Med J (Engl). 128:1102–1107. 2015. View Article : Google Scholar : PubMed/NCBI
39	Gu N, Peng J, Murugan M, Wang X, Eyo UB, Sun D, Ren Y, DiCicco-Bloom E, Young W, Dong H and Wu LJ: Spinal microgliosis due to resident microglial proliferation is required for pain hypersensitivity after peripheral nerve injury. Cell Rep. 16:605–614. 2016. View Article : Google Scholar : PubMed/NCBI
40	Battaglia AA, Sehayek K, Grist J, McMahon SB and Gavazzi I: EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat Neurosci. 6:339–340. 2003. View Article : Google Scholar : PubMed/NCBI
41	Epstein JB, Wilkie DJ, Fischer DJ, Kim YO and Villines D: Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol. 1:262009. View Article : Google Scholar : PubMed/NCBI
42	Ruscheweyh R, Wilder-Smith O, Drdla R, Liu XG and Sandkühler J: Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain. 7:202011. View Article : Google Scholar : PubMed/NCBI
43	Nakai K, Nakae A, Oba S, Mashimo T and Ueda K: P2X4 receptor expression in a rat model of trigeminal neuropathic pain. Neuroreport. 21:559–563. 2010. View Article : Google Scholar : PubMed/NCBI
44	Attal N: Neuropathic Pain: Mechanisms, therapeutic approach, and interpretation of clinical trials. Continuum (Minneap Minn). 18:161–175. 2012.PubMed/NCBI